4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid)

C98H95F15N30O15 — CID 157465728

IUPAC4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCC#CCn1c(N2CCNCC2)nc2cnn(Cc3c(F)cc(C(=O)NC)cc3C#N)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3cc(OCC)c(C(=O)NC)cc3C#N)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3ccc(F)c(C#N)c3)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3ccc(F)cc3C#N)c(=O)c21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C25H28N8O3.C23H23FN8O2.2C21H20FN7O.4C2HF3O2/c1-4-6-9-32-22-20(30-25(32)31-10-7-28-8-11-31)15-29-33(24(22)35)16-18-13-21(36-5-2)19(23(34)27-3)12-17(18)14-26;1-3-4-7-31-20-19(29-23(31)30-8-5-27-6-9-30)13-28-32(22(20)34)14-17-16(12-25)10-15(11-18(17)24)21(33)26-2;1-2-3-8-28-19-18(26-21(28)27-9-6-24-7-10-27)13-25-29(20(19)30)14-15-4-5-17(22)11-16(15)12-23;1-2-3-8-28-19-18(26-21(28)27-9-6-24-7-10-27)13-25-29(20(19)30)14-15-4-5-17(22)16(11-15)12-23;4*3-2(4,5)1(6)7/h12-13,15,28H,5,7-11,16H2,1-3H3,(H,27,34);10-11,13,27H,5-9,14H2,1-2H3,(H,26,33);2*4-5,11,13,24H,6-10,14H2,1H3;4*(H,6,7)
InChIKeyFGNOZRSREVLDAP-UHFFFAOYSA-N
MW2218.00 g/mol
LogP5.85
Rot. Bonds20

About 4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid)

4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid) (PubChem CID 157465728) has the molecular formula C98H95F15N30O15 and a molecular weight of 2218.00 g/mol. Its IUPAC name is 4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid).

Molecular Properties

Compound Name4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid)
PubChem CID157465728
Molecular FormulaC98H95F15N30O15
Molecular Weight2218.00 g/mol
Exact Mass2216.74
IUPAC Name4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid)
SMILESCC#CCn1c(N2CCNCC2)nc2cnn(Cc3c(F)cc(C(=O)NC)cc3C#N)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3cc(OCC)c(C(=O)NC)cc3C#N)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3ccc(F)c(C#N)c3)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3ccc(F)cc3C#N)c(=O)c21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C25H28N8O3.C23H23FN8O2.2C21H20FN7O.4C2HF3O2/c1-4-6-9-32-22-20(30-25(32)31-10-7-28-8-11-31)15-29-33(24(22)35)16-18-13-21(36-5-2)19(23(34)27-3)12-17(18)14-26;1-3-4-7-31-20-19(29-23(31)30-8-5-27-6-9-30)13-28-32(22(20)34)14-17-16(12-25)10-15(11-18(17)24)21(33)26-2;1-2-3-8-28-19-18(26-21(28)27-9-6-24-7-10-27)13-25-29(20(19)30)14-15-4-5-17(22)11-16(15)12-23;1-2-3-8-28-19-18(26-21(28)27-9-6-24-7-10-27)13-25-29(20(19)30)14-15-4-5-17(22)16(11-15)12-23;4*3-2(4,5)1(6)7/h12-13,15,28H,5,7-11,16H2,1-3H3,(H,27,34);10-11,13,27H,5-9,14H2,1-2H3,(H,26,33);2*4-5,11,13,24H,6-10,14H2,1H3;4*(H,6,7)
InChIKeyFGNOZRSREVLDAP-UHFFFAOYSA-N
XLogP5.85
TPSA583.71 Ų
H-Bond Donors10
H-Bond Acceptors39
Rotatable Bonds20
Heavy Atoms158
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002218.00
LogP ≤ 55.85
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1039

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze 4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid)?
The IUPAC name of 4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid) (CID 157465728) is 4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid).
What is the SMILES notation for 4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid)?
The canonical SMILES for 4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid) is CC#CCn1c(N2CCNCC2)nc2cnn(Cc3c(F)cc(C(=O)NC)cc3C#N)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3cc(OCC)c(C(=O)NC)cc3C#N)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3ccc(F)c(C#N)c3)c(=O)c21.CC#CCn1c(N2CCNCC2)nc2cnn(Cc3ccc(F)cc3C#N)c(=O)c21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.
What is the InChIKey of 4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid)?
The InChIKey is FGNOZRSREVLDAP-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H28N8O3.C23H23FN8O2.2C21H20FN7O.4C2HF3O2/c1-4-6-9-32-22-20(30-25(32)31-10-7-28-8-11-31)15-29-33(24(22)35)16-18-13-21(36-5-2)19(23(34)27-3)12-17(18)14-26;1-3-4-7-31-20-19(29-23(31)30-8-5-27-6-9-30)13-28-32(22(20)34)14-17-16(12-25)10-15(11-18(17)24)21(33)26-2;1-2-3-8-28-19-18(26-21(28)27-9-6-24-7-10-27)13-25-29(20(19)30)14-15-4-5-17(22)11-16(15)12-23;1-2-3-8-28-19-18(26-21(28)27-9-6-24-7-10-27)13-25-29(20(19)30)14-15-4-5-17(22)16(11-15)12-23;4*3-2(4,5)1(6)7/h12-13,15,28H,5,7-11,16H2,1-3H3,(H,27,34);10-11,13,27H,5-9,14H2,1-2H3,(H,26,33);2*4-5,11,13,24H,6-10,14H2,1H3;4*(H,6,7).
What are the key properties of 4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid)?
4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid) has a molecular weight of 2218.00 g/mol, XLogP of 5.85, 20 rotatable bonds, 10 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-cyano-2-ethoxy-N-methylbenzamide;4-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-3-cyano-5-fluoro-N-methylbenzamide;2-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-5-fluorobenzonitrile;5-[(3-but-2-ynyl-4-oxo-2-piperazin-1-ylimidazo[4,5-d]pyridazin-5-yl)methyl]-2-fluorobenzonitrile;tetrakis(2,2,2-trifluoroacetic acid) is sourced from PubChem (CID 157465728), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).